Live Lactobacillus Rhamnosus [corrected] is Essential for the Inhibitory Effect on Tumor Necrosis Factor Alpha-induced Interleukin-8 Expression

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2004 Aug 24

PMID 15322027

Citations 82

Authors

Donglai Ma

Paul Forsythe

John Bienenstock

Affiliations

Soon will be listed here.

Abstract

The mechanism of the apparent anti-inflammatory action of probiotic organisms is unclear. Lactobacillus reuteri is effective in inhibiting colitis in interleukin-10 (IL-10)-deficient mice. Nerve growth factor (NGF), in addition to its activity on neuronal cell growth, has significant anti-inflammatory effects in several experimental systems in vitro and in vivo, including a model of colitis. Our experiments were designed to explore the mechanism of effect of L. reuteri in the human epithelial cell lines T84 and HT29 on cytokine and NGF synthesis and IL-8 response to tumor necrosis factor alpha (TNF-alpha). Epithelial cells were cultured for various times with live and killed L. reuteri and examined by reverse transcription-PCR for NGF, IL-10, and TNF-alpha-induced IL-8 expression. An enzyme-linked immunosorbent assay was used to quantitate intracellular IL-8 and secreted product. Western blotting and confocal microscopy were used to determine the effects on IkappaB and NF-kappaB, respectively. Live but not heat-killed or gamma-irradiated L. reuteri upregulated NGF and dose dependently inhibited constitutive synthesis by T84 and HT29 cells of IL-8 and that induced by TNF-alpha in terms of mRNA and intracellular and secreted protein. Similarly, L. reuteri inhibited IL-8 synthesis induced by Salmonella enterica serovar Typhimurium. L. reuteri required preincubation and adherence for effect, inhibited translocation of NF-kappaB to the nuclei of HeLa cells, and prevented degradation of IkappaB. Neither cellular lysates nor media supernatants had any effect on TNF-alpha-induced IL-8. The conclusion is that L. reuteri has potent direct anti-inflammatory activity on human epithelial cells, which is likely to be related to the activity of ingested probiotics. L. reuteri also upregulates an unusual anti-inflammatory molecule, NGF, and inhibits NF-kappaB translocation to the nucleus.

Citing Articles

Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes.

Donati Zeppa S, Gervasi M, Bartolacci A, Ferrini F, Patti A, Sestili P Nutrients. 2024; 16(22).

PMID: 39599740 PMC: 11597803. DOI: 10.3390/nu16223951.

The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.

Maddineni G, Obulareddy S, Paladiya R, Korsapati R, Jain S, Jeanty H Ann Med Surg (Lond). 2024; 86(8):4714-4731.

PMID: 39118769 PMC: 11305784. DOI: 10.1097/MS9.0000000000002276.

Decoction derived from L. bulbs and Sojae Semen Praeparatum alleviates wind-cold-type common cold Nrf2/HO-1 pathway and modulation of level.

Jiang Y, Wei W, Zhou J, Qiu S, Yang Q, Huo J Front Pharmacol. 2024; 15:1364328.

PMID: 38803435 PMC: 11129017. DOI: 10.3389/fphar.2024.1364328.

The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.

Vakilpour A, Amini-Salehi E, Moghadam A, Keivanlou M, Letafatkar N, Habibi A Nutr Diabetes. 2024; 14(1):25.

PMID: 38729941 PMC: 11087547. DOI: 10.1038/s41387-024-00281-7.

The Microbiota-Gut-Brain Axis in Metabolic Syndrome and Sleep Disorders: A Systematic Review.

Dos Santos A, Galie S Nutrients. 2024; 16(3).

PMID: 38337675 PMC: 10857497. DOI: 10.3390/nu16030390.

References

Madsen K . The use of probiotics in gastrointestinal disease. Can J Gastroenterol. 2002; 15(12):817-22. DOI: 10.1155/2001/690741. View

Christensen H, Frokiaer H, Pestka J . Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2001; 168(1):171-8. DOI: 10.4049/jimmunol.168.1.171. View

Podolsky D . Inflammatory bowel disease. N Engl J Med. 2002; 347(6):417-29. DOI: 10.1056/NEJMra020831. View

Borruel N, Carol M, Casellas F, Antolin M, DE LARA F, Espin E . Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut. 2002; 51(5):659-64. PMC: 1773447. DOI: 10.1136/gut.51.5.659. View

Yan F, Polk D . Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002; 277(52):50959-65. PMC: 4006994. DOI: 10.1074/jbc.M207050200. View

Ma D, Wolvers D, Stanisz A, Bienenstock J . Interleukin-10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol. 2003; 284(5):R1323-9. DOI: 10.1152/ajpregu.00756.2002. View

Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E . Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003; 361(9372):1869-71. DOI: 10.1016/S0140-6736(03)13490-3. View

McCarthy J, OMahony L, OCallaghan L, Sheil B, Vaughan E, Fitzsimons N . Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003; 52(7):975-80. PMC: 1773705. DOI: 10.1136/gut.52.7.975. View

Kelly D, Campbell J, King T, Grant G, Jansson E, Coutts A . Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2003; 5(1):104-12. DOI: 10.1038/ni1018. View

10.

Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B . Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004; 126(2):520-8. DOI: 10.1053/j.gastro.2003.11.019. View

11.

Gorbach S . Bacterial diarrhoea and its treatment. Lancet. 1987; 2(8572):1378-82. DOI: 10.1016/s0140-6736(87)91267-0. View

12.

McCormick B, Colgan S, MILLER S, Madara J . Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol. 1993; 123(4):895-907. PMC: 2200157. DOI: 10.1083/jcb.123.4.895. View

13.

Miettinen M, Vuopio-Varkila J, Varkila K . Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun. 1996; 64(12):5403-5. PMC: 174537. DOI: 10.1128/iai.64.12.5403-5405.1996. View

14.

Hamid Q, Schotman E, Jacobson M, Walker S, Durham S . Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol. 1997; 99(2):254-60. DOI: 10.1016/s0091-6749(97)70106-4. View

15.

Kagnoff M, Eckmann L . Epithelial cells as sensors for microbial infection. J Clin Invest. 1997; 100(1):6-10. PMC: 508158. DOI: 10.1172/JCI119522. View

16.

Svanborg C, Godaly G, Hedlund M . Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol. 1999; 2(1):99-105. DOI: 10.1016/s1369-5274(99)80017-4. View

17.

Madsen K, Doyle J, Jewell L, Tavernini M, Fedorak R . Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999; 116(5):1107-14. DOI: 10.1016/s0016-5085(99)70013-2. View

18.

Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H . Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol. 2002; 32(2):105-10. DOI: 10.1111/j.1574-695X.2002.tb00541.x. View

19.

Reinshagen M, Rohm H, Steinkamp M, Lieb K, Geerling I, von Herbay A . Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology. 2000; 119(2):368-76. DOI: 10.1053/gast.2000.9307. View

20.

Baggiolini M, Loetscher P . Chemokines in inflammation and immunity. Immunol Today. 2000; 21(9):418-20. DOI: 10.1016/s0167-5699(00)01672-8. View